Home Industries Market Insights About Us Publisher Contact us

Global Active Pharmaceutical Ingredients (API) CDMO Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029

ReportID: 872450

|

Published Date: Jan-23

|

No. of Pages: 250

|

Categories: Life Sciences

|

Formate :

The A2Z Market Research report on “Global Active Pharmaceutical Ingredients (API) CDMO Market Report 2022 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029” offers strategic visions into the global Active Pharmaceutical Ingredients (API) CDMO market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2022 to 2029. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Active Pharmaceutical Ingredients (API) CDMO product vendors, and their latest developments.

This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2022 to 2029. The study highlights current market trends for Active Pharmaceutical Ingredients (API) CDMO and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Active Pharmaceutical Ingredients (API) CDMO market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Active Pharmaceutical Ingredients (API) CDMO market.

By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2029 for all the regions and sub-regions have also been provided in the report.

This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Active Pharmaceutical Ingredients (API) CDMO market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.

Some of the important players in Active Pharmaceutical Ingredients (API) CDMO market are:
Recipharm
Cambrex Corporation
Patheon (Thermo Fisher Scientific)
CordenPharma
Lonza
Siegfried
Catalent
Boehringer Ingelheim
Piramal Group
AbbVie
SGS Quay Pharmaceuticals
Aenova Group
Curia
Sterling Pharma Solutions
Eurofins CDMO

Market segmentation by Type:
Macromolecular API
Small Molecule API

Market segmentation by Application:
Clinical
Commercial
Others
Table of Content

Global Active Pharmaceutical Ingredients (API) CDMO Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029

Chapter 1 Active Pharmaceutical Ingredients (API) CDMO Market Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients (API) CDMO
1.2 Active Pharmaceutical Ingredients (API) CDMO Market Segmentation by Type
1.2.1 Global Production Market Share of Active Pharmaceutical Ingredients (API) CDMO by Type in 2022
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Active Pharmaceutical Ingredients (API) CDMO Market Segmentation by Application
1.3.1 Active Pharmaceutical Ingredients (API) CDMO Consumption Market Share by Application in 2022
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Active Pharmaceutical Ingredients (API) CDMO Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Active Pharmaceutical Ingredients (API) CDMO (2018-2029)

Chapter 2 Global Economic Impact on Active Pharmaceutical Ingredients (API) CDMO Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

Chapter 3 Global Active Pharmaceutical Ingredients (API) CDMO Market Competition by Manufacturers
3.1 Global Active Pharmaceutical Ingredients (API) CDMO Production and Share by Manufacturers (2022 and 2022)
3.2 Global Active Pharmaceutical Ingredients (API) CDMO Revenue and Share by Manufacturers (2022 and 2022)
3.3 Global Active Pharmaceutical Ingredients (API) CDMO Average Price by Manufacturers (2022 and 2022)
3.4 Manufacturers Active Pharmaceutical Ingredients (API) CDMO Manufacturing Base Distribution, Production Area and Product Type
3.5 Active Pharmaceutical Ingredients (API) CDMO Market Competitive Situation and Trends
3.5.1 Active Pharmaceutical Ingredients (API) CDMO Market Concentration Rate
3.5.2 Active Pharmaceutical Ingredients (API) CDMO Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion

Chapter 4 Global Active Pharmaceutical Ingredients (API) CDMO Production, Revenue (Value) by Region (2018-2022)
4.1 Global Active Pharmaceutical Ingredients (API) CDMO Production by Region (2018-2022)
4.2 Global Active Pharmaceutical Ingredients (API) CDMO Production Market Share by Region (2018-2022)
4.3 Global Active Pharmaceutical Ingredients (API) CDMO Revenue (Value) and Market Share by Region (2018-2022)
4.4 Global Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.5 North America Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.6 Europe Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.7 China Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.8 Japan Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.9 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)
4.10 India Active Pharmaceutical Ingredients (API) CDMO Production, Revenue, Price and Gross Margin (2018-2022)

Chapter 5 Global Active Pharmaceutical Ingredients (API) CDMO Supply (Production), Consumption, Export, Import by Regions (2018-2022)
5.1 Global Active Pharmaceutical Ingredients (API) CDMO Consumption by Regions (2018-2022)
5.2 North America Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)
5.3 Europe Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)
5.4 China Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)
5.5 Japan Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)
5.6 Southeast Asia Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)
5.7 India Active Pharmaceutical Ingredients (API) CDMO Production, Consumption, Export, Import by Regions (2018-2022)

Chapter 6 Global Active Pharmaceutical Ingredients (API) CDMO Production, Revenue (Value), Price Trend by Type
6.1 Global Active Pharmaceutical Ingredients (API) CDMO Production and Market Share by Type (2018-2022)
6.2 Global Active Pharmaceutical Ingredients (API) CDMO Revenue and Market Share by Type (2018-2022)
6.3 Global Active Pharmaceutical Ingredients (API) CDMO Price by Type (2018-2022)
6.4 Global Active Pharmaceutical Ingredients (API) CDMO Production Growth by Type (2018-2022)

Chapter 7 Global Active Pharmaceutical Ingredients (API) CDMO Market Analysis by Application
7.1 Global Active Pharmaceutical Ingredients (API) CDMO Consumption and Market Share by Application (2018-2022)
7.2 Global Active Pharmaceutical Ingredients (API) CDMO Consumption Growth Rate by Application (2018-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries

Chapter 8 Active Pharmaceutical Ingredients (API) CDMO Manufacturing Cost Analysis
8.1 Active Pharmaceutical Ingredients (API) CDMO Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API) CDMO

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Active Pharmaceutical Ingredients (API) CDMO Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Active Pharmaceutical Ingredients (API) CDMO Major Manufacturers in 2022
9.4 Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

Chapter 12 Global Active Pharmaceutical Ingredients (API) CDMO Market Forecast (2022-2029)
12.1 Global Active Pharmaceutical Ingredients (API) CDMO Production, Revenue Forecast (2022-2029)
12.2 Global Active Pharmaceutical Ingredients (API) CDMO Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Active Pharmaceutical Ingredients (API) CDMO Production Forecast by Type (2022-2029)
12.4 Global Active Pharmaceutical Ingredients (API) CDMO Consumption Forecast by Application (2022-2029)
12.5 Active Pharmaceutical Ingredients (API) CDMO Price Forecast (2022-2029)

Chapter 13 Appendix

Request For Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Request For List Of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any)

Price

Single User

US$2550

Multi User

US$4650

Corporate User

US$4650

Excel Datapack

US$1650

Download Sample Report

Kindly share your specific requirement (if any)
970580f357b66011f3ad9bfd8fd4652a.png

Global Active Pharmaceutical Ingredients (API) CDMO Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029